These gaps stem from systemic barriers, including limited access to early detection, follow-up delays and inequities in ...

Based on data including more than 788 million patient visits from more than 15,000 ophthalmologists, thousands of eyes were ...

Tzield, a monoclonal antibody approved for stage 2 Type 1 diabetes, now seeks approval for stage 3 disease based on trial ...

However, ongoing studies, including perianal fistulizing disease trials and the REASON study evaluating transmural healing, will address some of these knowledge gaps in the future. For patients, the ...

An expert discusses how underutilization of combination lipid-lowering therapies stems from overly complex guidelines, primary care providers managing multiple chronic diseases simultaneously, cost ...